China Catheters Market Overview, 2030

China's catheter industry is rapidly expanding, driven by local innovations, increasing numbers of procedures, and strategic reforms in healthcare. Initially dependent on imports from Western producers, the sector has transformed quickly over the last twenty years, with local companies now creating an extensive array of CE-marked and NMPA-approved products. The uses of catheters include fluid removal, drug delivery, access for diagnostics, and procedures in various fields such as cardiovascular, urological, neurovascular, and infusion. The growth of catheter usage in China began with the modernization of advanced hospitals and the introduction of minimally invasive methods in the early 2000s. Challenges faced included a lack of centralized procurement, insufficient training for healthcare providers, and elevated infection rates due to reusable devices. National measures for infection control, promotion of single-use coated catheters, and the incorporation of catheter care into clinical protocols have addressed these issues. Current types available are Foley catheters, PICC lines, central venous catheters, microcatheters, and balloon catheters each tailored to meet specific anatomical and procedural requirements. From a technical standpoint, catheters are flexible tubes used to reach internal cavities or blood vessels for draining, infusing, or intervening. Their advantages consist of shorter hospital stays, improved procedure management, and reduced infection risks, especially with the use of antimicrobial coatings and user-friendly designs. The industry has shifted from relying on imports to a strong domestic production capacity, bolstered by regulations such as NMPA Order 104 and Order 30, which simplify the approval process for locally made Class II and III devices. Hospitals are the main users, implementing catheters in surgical, emergency, and intensive care environments, while outpatient facilities and home healthcare programs are progressively using urinary and infusion catheters for ongoing care. Research and development trends are focusing on intelligent catheter systems that incorporate sensors, allow real-time monitoring, and utilize biocompatible coatings.

According to the research report, "China Catheters Market Overview, 2030," published by Bonafide Research, the China Catheters market is anticipated to grow at more than 7.75% CAGR from 2025 to 2030. This surge is fueled by increasing numbers of procedures, a higher incidence of chronic illnesses, and a shift towards local production. The industry, which has historically depended on imports, is now evolving towards homegrown manufacturing, aided by government initiatives like Made in China 2025 and Order 551 that promote locally produced medical devices. Recent advancements include the rise of single-use, coated, and sensor-equipped catheters, as well as cutting-edge infusion systems and microcatheters designed for less invasive operations. Leading companies include local giants such as Lepu Medical, MicroPort, and SCW Medicath, alongside international players like Medtronic, Boston Scientific, and B. Braun, who are increasingly collaborating with local entities to overcome procurement challenges and enhance market entry. New opportunities are arising in tier-2 and tier-3 municipalities, where enhancements in healthcare facilities and broader insurance coverage are bolstering the need for cardiovascular, urological, and infusion catheters. Localization plays a crucial role in market strategy local companies gain from quicker NMPA approvals, VAT benefits, and volume-based procurement VBP, while multinational corporations feel pressure to co-create, produce, or license technologies domestically to stay competitive. The vendor landscape is evolving, with local makers gaining ground through cost-effective innovations and nimbleness in regulations, while multinational companies retain dominance in premium market segments via partnerships and research and development centers. Significant factors for growth include the aging demographic in China, expected to surpass 400 million individuals over 60 by 2040, alongside increasing interest in minimally invasive procedures in fields like cardiology, oncology, and neurology. Compliance is regulated by the updated mandatory standards list from the NMPA 2024, ISO 13485 certifications, and Decree 739, which requires compliance with national or industry standards for registration.

China's catheter industry by product type is divided into Cardiovascular Catheters, Urological Catheters, Intravenous Catheters, Neurovascular Catheters, Infusion Catheters and Specialty Catheters & Others is quickly expanding across various product types, with each category playing essential roles in contemporary medical practices. Cardiovascular catheters are vital for treating heart conditions, particularly in interventional cardiology procedures like angioplasty, stent placement, and electrophysiological treatments. Leading hospitals such as Fuwai and Zhongshan are pioneers in utilizing advanced catheter techniques, which include ultrasound-assisted access and interventions without radiation. Urological catheters, which consist of Foley, Nelaton, and ureteral stents, are commonly utilized in urology wards for functions such as bladder drainage, managing stones, and handling post-operative recovery. Facilities like West China Hospital conduct thousands of urological procedures every month, utilizing hydrophilic-coated and silicone-based catheters that prioritize comfort and minimize infection risks. Intravenous catheters, including peripheral IVs, central venous catheters CVCs, and PICC lines, are frequently used in both surgical and emergency contexts. These devices facilitate quick fluid resuscitation, medication administration, and blood sampling, with advancements such as antimicrobial coatings and enclosed systems enhancing safety and diminishing complications. Neurovascular catheters are utilized in surgical procedures involving the brain and spine, particularly for stroke thrombectomy, aneurysm coiling, and AVM embolization. The neurovascular sector in China is experiencing growth of over 9% CAGR, with an increasing reliance on microcatheters and embolization devices in tertiary hospitals and specialized medical centers. Infusion catheters, such as elastomeric pumps and implanted ports, are crucial for providing chemotherapy, hydration, and prolonged medication delivery. Local companies are increasing the production of disposable infusion sets and advanced delivery systems to cater to the growing need. Specialty catheters employed in robotic-assisted surgeries, fecal management, and cardiac mapping highlight China's commitment to advanced medical technologies.

The catheters in China by distribution channel is divided into retail outlets, hospital establishments, and digital platforms, each fulfilling specific functions related to accessibility, logistics, and patient support. Retail outlets, which include licensed medical supply shops and certain pharmacies, provide the public with access to frequently utilized catheter products like intermittent urinary catheters, Foley kits, and accessories for infusion. These outlets hold significant importance in tier-2 and tier-3 cities, where access to hospitals may be restricted, and patients with chronic conditions need quick solutions. The availability of retail options is bolstered by China's growing number of community health facilities and the government's initiative to promote decentralized care. Hospital establishments function within organized procurement frameworks, supplying various types of catheters, including cardiovascular, intravenous, neurovascular, and specialized ones, for surgical, emergency, and intensive care units. These stores are managed through centralized logistics and regional bidding systems, ensuring sterile supplies, adherence to NMPA regulations, and conformity with clinical guidelines. Hospitals frequently depend on vendor-managed inventory and electronic tracking systems to enhance supply chains and minimize waste. Prominent distributors such as Jointown and Sinopharm are integral in providing continuity and technical assistance across both public and private healthcare facilities. These platforms facilitate self-catheterization, telehealth integration, and empower patients, particularly among older individuals and those facing mobility challenges. Access to online services also assists in handling regional reimbursement issues and product availability challenges. As China’s healthcare system evolves and moves towards decentralization, the relationship between retail, hospital, and online sectors becomes increasingly crucial, balancing clinical accuracy, patient convenience, and innovative procurement throughout the catheter supply network.

China's catheter market by end user is divided into hospitals and outpatient surgery centers (ASCs), homecare environments, and diagnostic facilities all of which illustrate the country's swiftly advancing healthcare system and the increasing need for minimally invasive treatments. Hospitals and ASCs serve as the primary consumers, especially in Tier 1 and Tier 2 cities like Beijing, Shanghai, Guangzhou, and Chengdu. These facilities utilize cardiovascular, neurovascular, intravenous, and specialized catheters in surgical rooms, ICUs, and emergency wards. As cardiovascular illnesses and strokes continue to be leading death causes, catheter-based procedures like angioplasty, thrombectomy, and chemotherapy delivery have become commonplace in tertiary hospitals and busy ASCs. The uptake of sophisticated catheter systems incorporating antimicrobial coatings, pressure sensors, and user-friendly designs is growing, aided by China's initiative for precise medicine and medical advancements. Homecare environments are seeing a rise in usage, especially among elderly individuals and those dealing with long-term health issues like diabetes, cancer, and neurogenic bladder. Infusion catheters, Foley catheters, and PICC lines are typically employed for ongoing treatment, urinary care, and nutritional needs. The growth of home healthcare models, backed by community health initiatives and digital health services, is allowing for safer, more customized catheter applications outside of hospitals. This movement is particularly significant in rural and semi-urban areas where access to healthcare facilities may be limited. Diagnostic facilities, such as imaging centers and interventional radiology departments, employ catheters for providing contrast fluids, vascular mapping, and targeted tissue sampling. Neurovascular and cardiovascular catheters are crucial for procedures like angiograms, CT-guided treatments, and endovascular diagnostics. These centers often associated with academic hospitals or running independently are vital for the early detection of diseases and accurate diagnostics. These user segments exemplify China's healthcare goals: achieving a balance between institutional quality, homecare growth, and diagnostic accuracy to satisfy the increasing demand for catheter-related care in various clinical settings.
Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030



Aspects covered in this report
• Catheters Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Cardiovascular Catheters
• Urological Catheters
• Intravenous Catheters
• Neurovascular Catheters
• Infusion Catheters
• Specialty Catheters & Others (Microcatheters and Drainage & Centesis Catheters)

By Distribution Channel
• Retail Stores
• Hospital Stores
• Online Stores

By End User
• Hospitals and Ambulatory Surgical Centers (ASCs)
• Homecare Settings
• Diagnostic Centers